The therapeutic and diagnostic role of exosomes in cardiovascular diseases

Trends in Cardiovascular Medicine

Volumn 29, Issue 6, 2019, Pages 313-323

  Zamani, Parvin ^a   Fereydouni, Narges ^b   Butler, Alexandra E ^c   Navashenaq, Jamshid Gholizadeh ^d   Sahebkar, Amirhossein ^b,e  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMAD BIN KHALIFA UNIVERSITY   (Qatar)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biomarker; Cardiovascular disease; Cell to cell communication; Exosomes

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; PROTEIN;

ATHEROSCLEROSIS; CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CELL COMMUNICATION; CELL COMPOSITION; CELL FUNCTION; EXOSOME; EXTRACELLULAR SPACE; GENE FUNCTION; HEART FAILURE; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; MYOCARDIAL DISEASE; NONHUMAN; ORGANELLE BIOGENESIS; PATHOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; ANIMAL; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC MARKER; GENETICS; METABOLISM; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; CARDIOVASCULAR DISEASES; CELL COMMUNICATION; EXOSOMES; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENETIC THERAPY; HUMANS; MICRORNAS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

EID: 85055466644     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2018.10.010     Document Type: Review

References (130)

1. Ieda, M., Heart development and regeneration via cellular interaction and reprogramming. Keio J Med 62:4 (2013), 99–106.
2. Souders, C.A., Bowers, S.L., Baudino, T.A., Cardiac fibroblast: the renaissance cell. Circ Res 105:12 (2009), 1164–1176.
3. Tirziu, D., Giordano, F.J., Simons, M., Cell communications in the heart. Circulation 122:9 (2010), 928–937.
4. Sheikh, F., Ross, R.S., Chen, J., Cell-cell connection to cardiac disease. Trends Cardiovasc Med 19:6 (2009), 182–190.
5. Kakkar, R., Lee, R.T., Intramyocardial fibroblast myocyte communication. Circ Res 106:1 (2010), 47–57.
6. Lionetti, V., Bianchi, G., Recchia, F.A., Ventura, C., Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. Heart Fail Rev 15:6 (2010), 531–542.
7. Ribeiro, M.F., Zhu, H., Millard, R.W., Fan, G.C., Exosomes function in pro-and anti-angiogenesis. Curr Angiogen, 2(1), 2013, 54.
8. Zhu, H., Fan, G.C., Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis, 1(2), 2011, 138.
9. Ailawadi, S., Wang, X., Gu, H., Fan, G.C., Pathologic function and therapeutic potential of exosomes in cardiovascular disease. Biochim et Biophys Acta Mol Bas Dis 1852:1 (2015), 1–11.
10. Johnsen, K.B., Gudbergsson, J.M., Skov, M.N., Pilgaard, L., Moos, T., Duroux, M., A comprehensive overview of exosomes as drug delivery vehicles—endogenous nanocarriers for targeted cancer therapy. Biochim et Biophys Acta Rev Cancer 1846:1 (2014), 75–87.
11. Vlassov, A.V., Magdaleno, S., Setterquist, R., Conrad, R., Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim et Biophys Acta Gen Subj 1820:7 (2012), 940–948.
12. Record, M., Carayon, K., Poirot, M., Silvente-Poirot, S., Exosomes as new vesicular lipid transporters involved in cell–cell communication and various pathophysiologies. Biochim et Biophys Acta Mol Cell Biol Lip 1841:1 (2014), 108–120.
13. Cosme, J., Liu, P.P., Gramolini, A.O., The cardiovascular exosome: current perspectives and potential. Proteomics 13:10-11 (2013), 1654–1659.
14. Wang, Y., Liang, J., Xu, J., Wang, X., Zhang, X., Wang, W., et al. Circulating exosomes and exosomal lncRNA HIF1A-AS1 in atherosclerosis. Int J Clin Exp Pathol 10:8 (2017), 8383–8388.
15. Shi, J., Kong, X., Exosomal microRNAs in cardiovascular diseases. Non coding RNA Investig, 1(4), 2017.
16. György, B., Szabó, T.G., Pásztói, M., Pál, Z., Misják, P., Aradi, B., et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68:16 (2011), 2667–2688.
17. Abels, E.R., Breakefield, X.O., Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. 2016, Springer.
18. Mathivanan, S., Ji, H., Simpson, R.J., Exosomes: extracellular organelles important in intercellular communication. J Proteom 73:10 (2010), 1907–1920.
19. Minciacchi, V.R., Freeman, M.R., Di Vizio, D., Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol, 2015 Elsevier.
20. Hristov, M., Erl, W., Linder, S., Weber, P.C., Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood 104:9 (2004), 2761–2766.
21. Pan, B.-T., Johnstone, R.M., Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33:3 (1983), 967–978.
22. Simpson, R.J., Lim, J.W., Moritz, R.L., Mathivanan, S., Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteom 6:3 (2009), 267–283.
23. Zakharova, L., Svetlova, M., Fomina, A.F., T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor. J Cell Physiol 212:1 (2007), 174–181.
24. Emanueli, C., Shearn, A.I., Angelini, G.D., Sahoo, S., Exosomes and exosomal miRNAs in cardiovascular protection and repair. Vasc Pharmacol 71 (2015), 24–30.
25. Hurley, J.H., ESCRT complexes and the biogenesis of multivesicular bodies. Curr Opin Cell Biol 20:1 (2008), 4–11.
26. Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:5867 (2008), 1244–1247.
27. Kajimoto, T., Okada, T., Miya, S., Zhang, L., Nakamura, S.I., Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes. Nat Commun, 4, 2013, 2712.
28. Ostrowski, M., Carmo, N.B., Krumeich, S., Fanget, I., Raposo, G., Savina, A., et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol, 12(1), 2010, 19.
29. Savina, A., Vidal, M., Colombo, M.I., The exosome pathway in K562 cells is regulated by Rab11. J Cell Sci 115:12 (2002), 2505–2515.
30. Ekström, E.J., Bergenfelz, C., von Bülow, V., Serifler, F., Carlemalm, E., Jönsson, G., et al. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Mol Cancer, 13(1), 2014, 88.
31. Vidal, M., Stahl, P., The small GTP-binding proteins Rab4 and ARF are associated with released exosomes during reticulocyte maturation. Eur J Cell Biol 60:2 (1993), 261–267.
32. Savina, A., Furlán, M., Vidal, M., Colombo, M.I., Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem 278:22 (2003), 20083–20090.
33. Lespagnol, A., Duflaut, D., Beekman, C., Blanc, L., Fiucci, G., Marine, J.-C., et al. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ, 15(11), 2008, 1723.
34. Chen, T., Guo, J., Yang, M., Zhu, X., Cao, X., Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol 186:4 (2011), 2219–2228.
35. Park, J.E., Tan, H.S., Datta, A., Lai, R.C., Zhang, H., Meng, W., et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteom 9:6 (2010), 1085–1099.
36. Gupta, S., Knowlton, A.A., HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol 292:6 (2007), H3052–H30H6.
37. Mathivanan, S., Simpson, R.J., ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 9:21 (2009), 4997–5000.
38. Choi, D.S., Kim, D.K., Kim, Y.K., Gho, Y.S., Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics 13:10-11 (2013), 1554–1571.
39. Thakur, B.K., Zhang, H., Becker, A., Matei, I., Huang, Y., Costa-Silva, B., et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res, 24(6), 2014, 766.
40. Gezer, U., Özgür, E., Cetinkaya, M., Isin, M., Dalay, N., Long non‐coding RNAs with low expression levels in cells are enriched in secreted exosomes. Cell Biol Int 38:9 (2014), 1076–1079.
41. Essandoh, K., Fan, G.C., Role of extracellular and intracellular microRNAs in sepsis. Biochim et Biophys Acta Mol Bas Dis 1842:11 (2014), 2155–2162.
42. Record, M., Subra, C., Silvente-Poirot, S., Poirot, M., Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81:10 (2011), 1171–1182.
43. Momtazi, A.A., Derosa, G., Maffioli, P., Banach, M., Sahebkar, A., Role of microRNAs in the therapeutic effects of curcumin in non-cancer diseases. Mol Diagn Ther 20:4 (2016), 335–345.
44. Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A.J., Zeiher, A.M., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol, 14(3), 2012, 249.
45. Halkein, J., Tabruyn, S.P., Ricke-Hoch, M., Haghikia, A., Scherr, M., Castermans, K., et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 123:5 (2013), 2143–2154.
46. Mirzaei, H.R., Sahebkar, A., Mohammadi, M., Yari, R., Salehi, H., Jafari, M.H., et al. Circulating micrornas in hepatocellular carcinoma: Potential diagnostic and prognostic biomarkers. Curr Pharm Design 22:34 (2016), 5257–5269.
47. Moridikia, A., Mirzaei, H., Sahebkar, A., Salimian, J., MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. J Cell Physiol 233:2 (2018), 901–913.
48. Momtazi, A.A., Banach, M., Pirro, M., Stein, E.A., Sahebkar, A., MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?. Clin Rev Allerg Immu 54:2 (2018), 224–233.
49. Tavasolian, F., Abdollahi, E., Rezaee, R., Momtazi-borojeni, A.A., Henrotin, Y., Sahebkar, A., Altered Expression of MicroRNAs in Rheumatoid Arthritis. J Cell Biochem 119:1 (2018), 478–487.
50. Mohajeri, M, Banach, M, Atkin, SL, Butler, AE, Ruscica, M, Watts, GF, et al. MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy. Trends Pharmacol Sci 39:11 (2018), 967–981, 10.1016/j.tips.2018.09.005.
51. Momtazi, A.A., Shahabipour, F., Khatibi, S., Johnston, T.P., Pirro, M., Sahebkar, A., Curcumin as a MicroRNA regulator in cancer: A review. Rev Physiol Bioch P 171 (2016), 1–38.
52. Ayati, S.H., Fazeli, B., Momtazi-borojeni, A.A., Cicero, A.F.G., Pirro, M., Sahebkar, A., Regulatory effects of berberine on microRNome in Cancer and other conditions. Crc Cr Rev Oncol-Hem 116 (2017), 147–158.
53. Yaribeygi, H., Katsiki, N., Behnam, B., Iranpanah, H., Sahebkar, A., MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment. Metabolis: Clin Exp 87 (2018), 48–55.
54. Tian, J., An, X., Niu, L., Role of microRNAs in cardiac development and disease. Exp Ther Med 13:1 (2017), 3–8.
55. Papageorgiou, N., Tousoulis, D., Androulakis, E., Siasos, G., Briasoulis, A., Vogiatzi, G., et al. The role of microRNAs in cardiovascular disease. Curr Med Chem 19:16 (2012), 2605–2610.
56. Matkovich, S.J., Van Booven, D.J., Youker, K.A., Torre-Amione, G., Diwan, A., Eschenbacher, W.H., et al. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 119:9 (2009), 1263–1271.
57. Pegtel, D.M., Cosmopoulos, K., Thorley-Lawson, D.A., van Eijndhoven, M.A., Hopmans, E.S., Lindenberg, J.L., et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci 107:14 (2010), 6328–6333.
58. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J.J., Lötvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 9(6), 2007, 654.
59. Bang, C., Batkai, S., Dangwal, S., Gupta, S.K., Foinquinos, A., Holzmann, A., et al. Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 124:5 (2014), 2136–2146.
60. Barile, L., Lionetti, V., Cervio, E., Matteucci, M., Gherghiceanu, M., Popescu, L.M., et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res 103:4 (2014), 530–541.
61. Wang, X., Huang, W., Liu, G., Cai, W., Millard, R.W., Wang, Y., et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J Mol Cell Cardiol 74 (2014), 139–150.
62. Ren, X.-P., Wu, J., Wang, X., Sartor, M.A., Qian, J., Jones, K., et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119:17 (2009), 2357–2366.
63. Wang, X., Qian, R., Zhang, W., Chen, S., Jin, H., Hu, R., MicroRNA‐320 expression in myocardial microvascular endothelial cells and its relationship with insulin‐like growth factor‐1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 36:2 (2009), 181–188.
64. Feng, B., Chakrabarti, S., miR-320 regulates glucose-induced gene expression in diabetes. ISRN Endocrinol, 2012, 2012.
65. Cordes, K.R., Sheehy, N.T., White, M.P., Berry, E.C., Morton, S.U., Muth, A.N., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 460(7256), 2009, 705.
66. Fang, X., Stroud, M.J., Ouyang, K., Fang, L., Zhang, J., Dalton, N.D., et al. Adipocyte-specific loss of PPARγ attenuates cardiac hypertrophy. JCI Insight, 1(16), 2016.
67. Cheng, M., Zhao, X., Wu, B., Mao, X., Yi, G., Zeng, Q., et al. Circulating exosomal miR-1a is markedly induced by myocardial infarction and downregulates CXCR4 expression in the bone marrow mononuclear cells. Am Heart Assoc, 2014.
68. Beltrami, C., Besnier, M., Shantikumar, S., Shearn, A.I., Rajakaruna, C., Laftah, A., et al. Human pericardial fluid contains exosomes enriched with cardiovascular-expressed microRNAs and promotes therapeutic angiogenesis. Mol Ther 25:3 (2017), 679–693.
69. Zhang, H., Liu, J., Qu, D., Wang, L., Wong, C.M., Lau, C.-W., et al. Serum exosomes mediate delivery of arginase 1 as a novel mechanism for endothelial dysfunction in diabetes. Proc Natl Acad Sci 115:29 (2018), E6927–E6936.
70. Ranganath, S.H., Levy, O., Inamdar, M.S., Karp, J.M., Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10:3 (2012), 244–258.
71. Sahoo, S., Klychko, E., Thorne, T., Misener, S., Schultz, K.M., Millay, M., et al. Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity. Circ Res, 111, 2011, 253286 CIRCRESAHA.
72. Lai, R.C., Arslan, F., Lee, M.M., Sze, N.S.K., Choo, A., Chen, T.S., et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4:3 (2010), 214–222.
73. Linke, A., Müller, P., Nurzynska, D., Casarsa, C., Torella, D., Nascimbene, A., et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. PNAS 102:25 (2005), 8966–8971.
74. Chen, L., Wang, Y., Pan, Y., Zhang, L., Shen, C., Qin, G., et al. Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem Biophys Res Commun 431:3 (2013), 566–571.
75. Brett, J.O., Renault, V.M., Rafalski, V.A., Webb, A.E., Brunet, A., The microRNA cluster miR-106b∼ 25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation. Aging, 3(2), 2011, 108 (Albany NY).
76. Glass, C., Singla, D.K., ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium. Mol Cell Biochem 357:1-2 (2011), 135–141.
77. Mittelbrunn, M., Gutiérrez-Vázquez, C., Villarroya-Beltri, C., González, S., Sánchez-Cabo, F., González, M.Á., et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun, 2, 2011, 282.
78. Gnecchi, M., Cervio, E., Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol 57:1 (2012), 48–55.
79. Feng, Y., Huang, W., Wani, M., Yu, X., Ashraf, M., Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One, 9(2), 2014, e88685.
80. Yu, B., Kim, H.W., Gong, M., Wang, J., Millard, R.W., Wang, Y., et al. Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol 182 (2015), 349–360.
81. Wang, K., Jiang, Z., Webster, K.A., Chen, J., Hu, H., Zhou, Y., et al. Enhanced cardioprotection by human endometrium mesenchymal stem cells driven by exosomal microRNA‐21. Stem Cells Transl Med 6:1 (2017), 209–222.
82. Durocher, D., Charron, F., Warren, R., Schwartz, R.J., Nemer, M., The cardiac transcription factors Nkx2‐5 and GATA‐4 are mutual cofactors. EMBO J 16:18 (1997), 5687–5696.
83. Gray, W.D., French, K.M., Ghosh-Choudhary, S., Maxwell, J.T., Brown, M.E., Platt, M.O., et al. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology novelty and significance. Circ Res 116:2 (2015), 255–263.
84. Dhalla, N.S., Temsah, R.M., Netticadan, T., Role of oxidative stress in cardiovascular diseases. J Hypertens 18:6 (2000), 655–673.
85. Xiao, J., Pan, Y., Li, X., Yang, X., Feng, Y., Tan, H., et al. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death Dis, 7(6), 2016, e2277.
86. Kishore, R., Khan, M., Cardiac cell-derived exosomes: changing face of regenerative biology. 2016, Oxford University Press.
87. Ibrahim, A.G.-E., Cheng, K., Marbán, E., Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep 2:5 (2014), 606–619.
88. Mayhall, E.A., Paffett-Lugassy, N., Zon, L.I., The clinical potential of stem cells. Curr Opin Cell Biol 16:6 (2004), 713–720.
89. Khan, M., Nickoloff, E., Abramova, T., Johnson, J., Verma, S.K., Krishnamurthy, P., et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res, 115, 2015, 305990 CIRCRESAHA.
90. Wang, Y., Zhang, L., Li, Y., Chen, L., Wang, X., Guo, W., et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol 192 (2015), 61–69.
91. Devaux, Y., Zangrando, J., Schroen, B., Creemers, E.E., Pedrazzini, T., Chang, C.-P., et al. Long noncoding RNAs in cardiac development and ageing. Nat Rev Cardiol, 12(7), 2015, 415.
92. Gomes, C.P., Spencer, H., Ford, K.L., Michel, L.Y., Baker, A.H., Emanueli, C., et al. The function and therapeutic potential of long non-coding RNAs in cardiovascular development and disease. Mol Ther Nucleic Acids 8 (2017), 494–507.
93. Kogure, T., Yan, I.K., Lin, W.-L., Patel, T., Extracellular vesicle–mediated transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular cancer. Genes Cancer 4:7-8 (2013), 261–272.
94. Chen, L., Yang, W., Guo, Y., Chen, W., Zheng, P., Zeng, J., et al. Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis. PLoS One, 12(9), 2017, e0185406.
95. Yang, Y., Cai, Y., Wu, G., Chen, X., Liu, Y., Wang, X., et al. Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease. Clin Sci, 2015, CS20150121.
96. Lakhal, S., Wood, M.J., Exosome nanotechnology: an emerging paradigm shift in drug delivery. Bioessays 33:10 (2011), 737–741.
97. Shahabipour, F, Barati, N, Johnston, TP, Derosa, G, Maffioli, P, Sahebkar, A, Exosomes: Nanoparticulate tools for RNA interference and drug delivery. J Cell Physiol 232:7 (2017), 1660–1668, 10.1002/jcp.25766.
98. Shahabipour, F, Banach, M, Sahebkar, A, Exosomes as nanocarriers for siRNA delivery: paradigms and challenges. Arch Med Sci 12:6 (2016), 1324–1326.
99. Torchilin, V.P., Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov, 4(2), 2005, 145.
100. Yellon, D.M., Davidson, S.M., Exosomes: nanoparticles involved in cardioprotection?. Circ Res 114:2 (2014), 325–332.
101. Mackie, A.R., Klyachko, E., Thorne, T., Schultz, K.M., Millay, M., Ito, A., et al. Sonic hedgehog–modified human CD34+ cells preserve cardiac function after acute myocardial infarction. Circ Res 111:3 (2012), 312–321.
102. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., Wood, M.J., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol, 29(4), 2011, 341.
103. Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 18:9 (2010), 1606–1614.
104. Jansen, F, Li, Q, Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases. Adv Exp Med Biol 998 (2017), 61–70, 10.1007/978-981-10-4397-0_4.
105. Mirzaei, H, Sahebkar, A, Jaafari, MR, Goodarzi, M, Mirzaei, HR, Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?. J Cell Physiol 232:12 (2017), 3251–3260, 10.1002/jcp.25739.
106. Li, C., Pei, F., Zhu, X., Duan, D.D., Zeng, C., Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clin Biochem 45:10-11 (2012), 727–732.
107. Kuwabara, Y., Ono, K., Horie, T., Nishi, H., Nagao, K., Kinoshita, M., et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate the existence of myocardial damage. Circ Genom Precis Med, 110, 2011, 958975 CIRCGENETICS.
108. Cheng, Y., Wang, X., Yang, J., Duan, X., Yao, Y., Shi, X., et al. A translational study of urine miRNAs in acute myocardial infarction. J Mol Cell Cardiol 53:5 (2012), 668–676.
109. Sayed, A.S.M., Xia, K., Yang, T.-L., Peng, J., Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction. Dis Mark 35:5 (2013), 561–566.
110. D'alessandra, Y., Devanna, P., Limana, F., Straino, S., Di Carlo, A., Brambilla, P.G., et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31:22 (2010), 2765–2773.
111. Oerlemans, M.I., Mosterd, A., Dekker, M.S., de Vrey, E.A., van Mil, A., Pasterkamp, G., et al. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Mol Med 4:11 (2012), 1176–1185.
112. Deddens, J.C., Vrijsen, K.R., Colijn, J.M., Oerlemans, M.I., Metz, C.H., van der Vlist, E.J., et al. Circulating extracellular vesicles contain miRNAs and are released as early biomarkers for cardiac injury. J Cardiovasc Transl Res 9:4 (2016), 291–301.
113. Chen, Y., Song, Y., Huang, J., Qu, M., Zhang, Y., Geng, J., et al. Increased circulating exosomal miRNA-223 is associated with acute ischemic stroke. Front Neurol, 8, 2017, 57.
114. Divakaran, V., Mann, D.L., The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 103:10 (2008), 1072–1083.
115. Small, E.M., Olson, E.N., Pervasive roles of microRNAs in cardiovascular biology. Nature, 469(7330), 2011, 336.
116. Matsumoto, S., Sakata, Y., Nakatani, D., Suna, S., Usami, M., Hara, M., et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res, 113, 2013, 301209 CIRCRESAHA.
117. Jansen, F., Yang, X., Proebsting, S., Hoelscher, M., Przybilla, D., Baumann, K., et al. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc, 3(6), 2014, e001249.
118. Natarelli, L., Schober, A., MicroRNAs and the response to injury in atherosclerosis. Hämostaseologie 35:02 (2015), 142–150.
119. Goren, Y., Kushnir, M., Zafrir, B., Tabak, S., Lewis, B.S., Amir, O., Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail 14:2 (2012), 147–154.
120. de Jong, O.G., Verhaar, M.C., Chen, Y., Vader, P., Gremmels, H., Posthuma, G., et al. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles, 1(1), 2012, 18396.
121. Yu, X., Deng, L., Wang, D., Li, N., Chen, X., Cheng, X., et al. Mechanism of TNF-α autocrine effects in hypoxic cardiomyocytes: initiated by hypoxia inducible factor 1α, presented by exosomes. J Mol Cell Cardiol 53:6 (2012), 848–857.
122. Pironti, G., Strachan, R.T., Abraham, D., Yu, S.M.-W., Chen, M., Chen, W., et al. Circulating exosomes induced by cardiac pressure overload contain functional angiotensin II type 1 receptors. Circulation, 115, 2015, 015687 CIRCULATIONAHA.
123. de Hoog, V.C., Timmers, L., Schoneveld, A.H., Wang, J.-W., van de Weg, S.M., Sze, S.K., et al. Serum extracellular vesicle protein levels are associated with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care 2:1 (2013), 53–60.
124. Cheow, E.S.H., Cheng, W.C., Lee, C.N., De Kleijn, D., Sorokin, V., Sze, S.K., Plasma-derived extracellular vesicles contain predictive biomarkers and potential therapeutic targets for myocardial ischemic (MI) injury. Mol Cell Proteom 15:8 (2016), 2628–2640.
125. Kennel, P.J., Saha, A., Maldonado, D.A., Givens, R., Brunjes, D.L., Castillero, E., et al. Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection. J Heart Lung Transplant 37:3 (2018), 409–417.
126. Xu, B., Fu, Y., Liu, Y., Agvanian, S., Wirka, R.C., Baum, R., et al. The ESCRT-III pathway facilitates cardiomyocyte release of cBIN1-containing microparticles. PLoS Biol, 15(8), 2017, e2002354.
127. Szatanek, R., Baran, J., Siedlar, M., Baj-Krzyworzeka, M.J.I.jomm, Isolation of extracellular vesicles: determining the correct approach. Int J Mol Med 36:1 (2015), 11–17.
128. Marcus, M.E., Leonard, J.N.J.P., FedExosomes: engineering therapeutic biological nanoparticles that truly deliver. Pharmaceuticals 6:5 (2013), 659–680.
129. Emanueli, C., Shearn, A.I., Laftah, A., Fiorentino, F., Reeves, B.C., Beltrami, C., et al. Coronary artery-bypass-graft surgery increases the plasma concentration of exosomes carrying a cargo of cardiac microRNAs: an example of exosome trafficking out of the human heart with potential for cardiac biomarker discovery. PLoS One, 11(4), 2016, e0154274.
130. Matsumoto, S., Sakata, Y., Suna, S., Nakatani, D., Usami, M., Hara, M., et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res 113:3 (2013), 322–326.